Therefore, measurement of ACE activity/levels in the blood, after adjustment for hormonal status and ACE genotype, may help to identify individuals with the lowest levels of tissue ACE expression who may be at risk for the development of late-onset Alzheimer’s disease. Here, ACE is linked to early-onset autosomal dominant Alzheimer disease.